U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
NIVATROTAMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL 3F8 .KAPPA.-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (TS(GGGGS)3) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL OKT3 SINGL
Common Name English
NIVATROTAMAB [USAN]
Common Name English
HU3F8BSAB
Code English
HU3F8-BSAB
Code English
nivatrotamab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 767020
Created by admin on Sat Dec 16 15:46:25 GMT 2023 , Edited by admin on Sat Dec 16 15:46:25 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C158436
Created by admin on Sat Dec 16 15:46:25 GMT 2023 , Edited by admin on Sat Dec 16 15:46:25 GMT 2023
PRIMARY
CAS
2278244-14-5
Created by admin on Sat Dec 16 15:46:25 GMT 2023 , Edited by admin on Sat Dec 16 15:46:25 GMT 2023
PRIMARY
FDA UNII
8RV18E4A94
Created by admin on Sat Dec 16 15:46:25 GMT 2023 , Edited by admin on Sat Dec 16 15:46:25 GMT 2023
PRIMARY
INN
11591
Created by admin on Sat Dec 16 15:46:25 GMT 2023 , Edited by admin on Sat Dec 16 15:46:25 GMT 2023
PRIMARY
ACTIVE MOIETY
NIVATROTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966